GlassScriptPrepare for your visit
Michael R Hossack
Neurology (Psychiatry & Neurology) · Nellis Afb, NV · NPI 1104246370
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,432.74
in general payments reported to CMS, 2019-2025 · $24.15 in 2025
The $24.15 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Who reported paying
General payments only, top 6 by amount.
- Rivanna Medical, INC $675.00
- Smith+Nephew, INC. $208.36
- Ucb, INC. $153.20
- Acorda Therapeutics, INC $145.81
- Tg Therapeutics, INC. $115.84
- Argenx US, INC. $76.75
Drugs and devices associated with these payments
Accuro Briumvi Qutenza
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Michael Hossack listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1391897/michael-r-hossack